Details for Patent: 8,513,247
✉ Email this page to a colleague
Which drugs does patent 8,513,247 protect, and when does it expire?
Patent 8,513,247 protects MIRVASO and is included in one NDA.
This patent has eighty-nine patent family members in twenty-five countries.
Summary for Patent: 8,513,247
| Title: | Methods and compositions for safe and effective treatment of erythema |
| Abstract: | Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier. |
| Inventor(s): | Graeber; Michael (Lawrenceville, NJ), Loesche; Christian (Valbonne, FR), Freidenreich; Philip (Yardley, PA), Liu; Yin-Sang (Princeton, NJ), Leoni; Matthew J. (Hampton, NJ) |
| Assignee: | Galderma Laboratories, L.P. (Fort Worth, TX) |
| Application Number: | 13/072,096 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,513,247 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,513,247
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | MIRVASO | brimonidine tartrate | GEL;TOPICAL | 204708-001 | Aug 23, 2013 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,513,247
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1631293 | ⤷ Sign Up | CR 2014 00031 | Denmark | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | C300683 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | 1490049-2 | Sweden | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | C20140022 00150 | Estonia | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | 92462 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
